These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

362 related articles for article (PubMed ID: 25999139)

  • 1. Atrial and Brain Natriuretic Peptide Secretion After Percutaneous Closure of the Left Atrial Appendage With the Watchman Device.
    Majunke N; Sandri M; Adams V; Daehnert I; Mangner N; Schuler G; Moebius-Winkler S
    J Invasive Cardiol; 2015 Oct; 27(10):448-52. PubMed ID: 25999139
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain natriuretic peptide levels variation after left atrial appendage occlusion.
    Cruz-Gonzalez I; Palazuelos Molinero J; Valenzuela M; Rada I; Perez-Rivera JA; Arribas Jimenez A; Gabella T; Prieto AB; Martín Polo J; Sánchez PL
    Catheter Cardiovasc Interv; 2016 Jan; 87(1):E39-43. PubMed ID: 26033157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atrial natriuretic peptide and brain natriuretic peptide changes after epicardial percutaneous left atrial appendage suture ligation using LARIAT device.
    Bartus K; Podolec J; Lee RJ; Kapelak B; Sadowski J; Bartus M; Oles K; Ceranowicz P; Trabka R; Litwinowicz R
    J Physiol Pharmacol; 2017 Feb; 68(1):117-123. PubMed ID: 28456775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serial Assessment of Natriuretic Peptides in Patients Undergoing Interventional Closure of the Left Atrial Appendage.
    Luani B; Rauwolf T; Groscheck T; Tanev I; Herold J; Isermann B; Schmeisser A; Braun-Dullaeus RC
    Heart Lung Circ; 2018 Jul; 27(7):828-834. PubMed ID: 28818408
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Results of Left Atrial Appendage Closure with Watchman Device in Patients with Atrial Fibrillation.
    Pheerawong P; Songmuang SB; Lertsuwunseri V; Satitthummanid S; Srimahachota S
    J Med Assoc Thai; 2015 Oct; 98(10):942-9. PubMed ID: 26638585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Catheter ablation in combination with left atrial appendage closure for atrial fibrillation.
    Swaans MJ; Alipour A; Rensing BJ; Post MC; Boersma LV
    J Vis Exp; 2013 Feb; (72):e3818. PubMed ID: 23486416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Correlation between plasma brain natriuretic peptide levels and left atrial appendage flow velocity in patients with non-valvular atrial fibrillation and normal left ventricular systolic function.
    Harada M; Tabako S; Fujii Y; Takarada Y; Hayashi K; Ohara H; Hara F; Ikeda T
    J Echocardiogr; 2018 Jun; 16(2):72-80. PubMed ID: 29256043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The impact of percutaneous left atrial appendage closure on left ventricular diastolic function and natriuretic peptide levels.
    Şabanoğlu C; Okutucu S; Halil İnanç I; Yorgun H; Aytemir K; Oto A
    Eur Rev Med Pharmacol Sci; 2021 Dec; 25(23):7418-7424. PubMed ID: 34919244
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of B-type natriuretic peptide level on the risk of left atrial appendage thrombus in patients with nonvalvular atrial fibrillation: a prospective study.
    Pant R; Patel M; Garcia-Sayan E; Wassouf M; D'Silva O; Kehoe RF; Doukky R
    Cardiovasc Ultrasound; 2016 Jan; 14():4. PubMed ID: 26772738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac CT and echocardiographic evaluation of peri-device flow after percutaneous left atrial appendage closure using the AMPLATZER cardiac plug device.
    Jaguszewski M; Manes C; Puippe G; Salzberg S; Müller M; Falk V; Lüscher T; Luft A; Alkadhi H; Landmesser U
    Catheter Cardiovasc Interv; 2015 Feb; 85(2):306-12. PubMed ID: 25205611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of left ventricular diastolic function on natriuretic peptide levels after cardioversion of atrial fibrillation.
    Bakowski D; Wozakowska-Kapłon B; Opolski G
    Kardiol Pol; 2009 Apr; 67(4):361-7. PubMed ID: 19492248
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Percutaneous closure of left atrial appendage in non-valvular atrial fibrillation--international and Hungarian experiences].
    Fontos G; Andréka P; Temesvári A; Wéber D; Szatmári A
    Orv Hetil; 2010 May; 151(18):725-34. PubMed ID: 20409999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparing Measurements of CT Angiography, TEE, and Fluoroscopy of the Left Atrial Appendage for Percutaneous Closure.
    Saw J; Fahmy P; Spencer R; Prakash R; McLaughlin P; Nicolaou S; Tsang M
    J Cardiovasc Electrophysiol; 2016 Apr; 27(4):414-22. PubMed ID: 26728988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in Left Atrial Appendage Dimensions Following Volume Loading During Percutaneous Left Atrial Appendage Closure.
    Spencer RJ; DeJong P; Fahmy P; Lempereur M; Tsang MYC; Gin KG; Lee PK; Nair P; Tsang TSM; Jue J; Saw J
    JACC Cardiovasc Interv; 2015 Dec; 8(15):1935-1941. PubMed ID: 26738661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of Left Atrial Appendage Amputation on Natriuretic Peptides-A Randomized Controlled Trial.
    Grieshaber P; Arneth B; Steinsberger F; Niemann B; Oswald I; Renz H; Böning A
    Thorac Cardiovasc Surg; 2021 Mar; 69(2):117-123. PubMed ID: 30929250
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Left atrial appendage closure with the Watchman device using intracardiac vs transesophageal echocardiography: Procedural and cost considerations.
    Hemam ME; Kuroki K; Schurmann PA; Dave AS; Rodríguez DA; Sáenz LC; Reddy VY; Valderrábano M
    Heart Rhythm; 2019 Mar; 16(3):334-342. PubMed ID: 30827462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term safety and efficacy of left atrial appendage closure with the WATCHMAN device in patients with small left atrial appendage ostia.
    Venkataraman G; Strickberger SA; Doshi S; Ellis CR; Lakkireddy D; Whalen SP; Cuoco F
    J Cardiovasc Electrophysiol; 2018 Jan; 29(1):17-21. PubMed ID: 28877379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Left atrial enlargement and clinical considerations in patients with or without a residual interatrial shunt after closure of the left atrial appendage with the WATCHMAN™-device.
    Luani B; Groscheck T; Genz C; Tanev I; Rauwolf T; Herold J; Medunjanin S; Schmeisser A; Braun-Dullaeus RC
    BMC Cardiovasc Disord; 2017 Dec; 17(1):294. PubMed ID: 29233088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous Closure of Left Atrial Appendage affects Mid-Term Release of MR-proANP.
    Behnes M; Sartorius B; Wenke A; Lang S; Hoffmann U; Fastner C; Borggrefe M; Roth T; Triebel J; Bertsch T; Akin I
    Sci Rep; 2017 Aug; 7(1):9028. PubMed ID: 28831085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Amulet or Watchman Device for Percutaneous Left Atrial Appendage Closure: Primary Results of the SWISS-APERO Randomized Clinical Trial.
    Galea R; De Marco F; Meneveau N; Aminian A; Anselme F; Gräni C; Huber AT; Teiger E; Iriart X; Babongo Bosombo F; Heg D; Franzone A; Vranckx P; Fischer U; Pedrazzini G; Bedogni F; Räber L; Valgimigli M
    Circulation; 2022 Mar; 145(10):724-738. PubMed ID: 34747186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.